Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DKN-01 in WNT-activated Hepatocellular Carcinoma
NCT03645980Phase 2Unknown
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Oct 2018
- Primary completion
- Aug 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sirexatamab in hepatocellular carcinoma (HCC), sponsored by Johannes Gutenberg University Mainz. Status: unknown.
02
Drugs
sirexatamab
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03645980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03645980.